Kebudi, R. Et Al. 2022. IMPACT OF ADDING MIFAMURTIDE TO A NON-METHOTREXATE THREE-DRUG CHEMOTHERAPY REGIMEN. PEDIATRIC BLOOD & CANCER , vol.69 .

Kebudi, R., Buyukkapu, S. B., Yildirim, U. M., & Salduz, A., (2022). IMPACT OF ADDING MIFAMURTIDE TO A NON-METHOTREXATE THREE-DRUG CHEMOTHERAPY REGIMEN. PEDIATRIC BLOOD & CANCER , vol.69.

Kebudi, Rejin Et Al. "IMPACT OF ADDING MIFAMURTIDE TO A NON-METHOTREXATE THREE-DRUG CHEMOTHERAPY REGIMEN," PEDIATRIC BLOOD & CANCER , vol.69, 2022

Kebudi, Rejin Et Al. "IMPACT OF ADDING MIFAMURTIDE TO A NON-METHOTREXATE THREE-DRUG CHEMOTHERAPY REGIMEN." PEDIATRIC BLOOD & CANCER , vol.69, 2022

Kebudi, R. Et Al. (2022) . "IMPACT OF ADDING MIFAMURTIDE TO A NON-METHOTREXATE THREE-DRUG CHEMOTHERAPY REGIMEN." PEDIATRIC BLOOD & CANCER , vol.69.

@article{article, author={Rejin KEBUDİ Et Al. }, title={IMPACT OF ADDING MIFAMURTIDE TO A NON-METHOTREXATE THREE-DRUG CHEMOTHERAPY REGIMEN}, journal={PEDIATRIC BLOOD & CANCER}, year=2022}